3858 results for «81»
3858 results
Bicuspid valves - Imaging, sizing and technical considerations for success
18 Feb 2023 – From PCR Tokyo Valves 2023
Watch this session to learn more about bicuspid aortic valves: understand the anatomical considerations that define patient selection, explore contemporary sizing strategies and participate in case-based discussions that highlight treatment strategies for bicuspid aortic stenosis.
Predictability and control: Evolut procedural approaches
18 Feb 2023 – From PCR Tokyo Valves 2023
In this session, delve into Evolut procedural approaches. You will be examining the cusp overlap technique, its latest clinical data and outcomes of the Medtronic's newest generational technology: Evolut FX.
Factors to consider during lifetime planning for TAVI patients
19 Feb 2023 – From PCR Tokyo Valves 2023
In this session, explore factors influencing lifetime prognosis and complication avoidance strategies in TAVI patients, focusing on pacemaker and paravalvular leak risk factors.
Left main - DK crush stenting: LIVE case from National University Heart Centre - Singapore
06 Oct 2022 – From AICT-AsiaPCR 2022
Abstracts - Coronary interventions - Session 1
06 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 1
06 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 3
06 Oct 2022 – From AICT-AsiaPCR 2022
AICT-AsiaPCR 2023 Awards Ceremony
22 Sep 2023 – From AICT-AsiaPCR 2023
With a record number of abstracts and clinical cases submitted this year, the winners of these AICT-AsiaPCR 2023 awards have done an excellent job, as the selection process was extremely rigorous. Find out more about the finalists, their reactions and the works that led them to...
AICT-AsiaPCR 2023 Closing Ceremony
22 Sep 2023 – From AICT-AsiaPCR 2023
As AICT-AsiaPCR 2023 draws to a close, it's time to say thank you to the 950 participants and all those who helped make the conference a success, both on stage and behind the scenes.
Clinical cases - Coronary interventions - Session 2
06 Oct 2022 – From AICT-AsiaPCR 2022
Revolutionising coronary calcium treatment: unleashing the potential of intravascular lithotripsy
21 Sep 2023 – From AICT-AsiaPCR 2023
Over the last five years, we have learned that there is a new tool for treating calcium, the greatest enemy of interventional cardiology, which can take various forms: intravascular lithotripsy. In this session, look at how to master this technique in different scenarios, from eccentric calcified...
The importance of SEE-PREP-TREAT in left main bifurcation
22 Sep 2023 – From AICT-AsiaPCR 2023
This session is recommended for you if you are seeking insights into the advantages of using IVUS imaging over visual assessment for better outcomes in left main bifurcation procedures. Discuss with experts the benefits of using RotaCUT in lesion preparation for left main bifurcation and explore...
Abstracts - Coronary interventions - Session 3
07 Oct 2022 – From AICT-AsiaPCR 2022
Abstracts - Coronary interventions - Session 4
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Structural interventions - Session 7
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Structural interventions - Session 9
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 8
07 Oct 2022 – From AICT-AsiaPCR 2022
Outcome of women in different cardiovascular interventions
06 Oct 2022 – From AICT-AsiaPCR 2022
AICT-AsiaPCR 2023 Opening Ceremony
21 Sep 2023 – From AICT-AsiaPCR 2023
This opening ceremony of the 2023 edition of the AICT-AsiaPCR congress provides an opportunity for its Directors and co-Directors to present the programme, of course, but also to offer several prestigious awards, to introduce the Asian Pacific Society of Interventional Cardiology (APSIC) and its missions, and...
Percutaneous treatment of pure aortic regurgitation: a new indication
21 Sep 2023 – From AICT-AsiaPCR 2023
Analyse the case of an 83-year-old male patient with history of HT, parkinson's disease and minor stroke, who presented with worsening exertional SOB, LVEF 55-60 %, dilated LV, mild MR, and severe AR, and study the different options to treat aortic regurgitation.
